External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer We evaluated chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results